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Biomarker of Mild Alzheimer’s DiseaseAlthough several postmortem ﬁndings in the retina of patients with
Alzheimer’s disease (AD) are available,1 new biomarkers for early
diagnosis and follow-up of AD are still lacking. It has been postu-
lated that the defects in the retinal nerveﬁber layer (RNFL)may be the
earliest signofAD, evenbeforedamage to the hippocampal region that
affects memory.2 This fact may reﬂect retinal neuronal-ganglion cell
death and axonal loss in the optic nerve in addition to aging.1
Changes in longitudinal optical coherence tomography (OCT)
measurements of RNFL can act as a surrogate marker of axonal
health, making OCT an invaluable tool for measuring axonal loss
as a biomarker.2 The goal of this study was to examine the
thickness of the macular and peripapillary RNFL with OCT to
determine the most predictive area affected in patients with mild
AD, Geriatric Depression Scale-4, Reisberg scale, and make
comparisons using normal subjects.
Twenty patients with mild AD and 28 age-matched control
subjects from the Geriatric Unit in the Hospital Clínico San Carlos,
Madrid, Spain, were studied. The AD patients met the criteria for
AD according to the National Institute of Neurological and
Communicative Disorders and StrokeeAlzheimer’s Disease and
Related Disorders Association and the Diagnostic and Statistical
Manual of Mental Disorders IV, having mild cognitive impairment
according to the Clinical Dementia Rating scale. Informed consent
was obtained from both groups. The research followed the tenets of
the Declaration of Helsinki, and the protocol was approved by the
local ethics committee.
The inclusion criteria for patients were: being free of ocular disease
and systemic disorders affecting vision; best-corrected visual acuity
(BCVA) of 20/40; 5 spherocylindrical refractive error; and intraoc-
ular pressure of <20 mmHg. All the subjects underwent a complete
ophthalmologic examination, including visual acuity, refraction,
anterior and posterior segment biomicroscopy, intraocular pressure
measurement, dilated fundus examination, and OCT. The RNFL
thickness and macular thickness were measured by OCT Model 3D
OCT-1000 (Topcon, Japan) after pupil dilatation. The analysis area
was centered manually and the absence of segmentation errors was
conﬁrmed for each scan. One eye of each patient assigned at random
was analyzed. In the peripapillary area the average thickness (360)
and the temporal (316e45), superior (46e135), nasal
(136e225), and inferior (226e315) quadrant thicknesses were
evaluated. Macular RNFL thickness data were displayed in 3
concentric rings centered in the foveola, distributed as follows: A
central macular ring, 1 mm from the fovea; an inner macular ring, 3
mm from the fovea; and an outer macular ring, 6 mm from the fovea.
The inner and outer rings were each divided into 4 quadrants (superior,
inferior, nasal, and temporal (Fig 1).
The data are reported as mean values  standard deviations.
The differences between groups were analyzed using the Manne
Whitney U test. Sensitivity at 90% speciﬁcity and receiver operating
characteristics (ROCs) analysis for discriminating between healthy
and mild AD patients were calculated for the RNFL thickness in all
the areas studied. Data were processed in a SPSS 19.0. P< 0.05 was
considered statistically signiﬁcant.A7987_proofwere no statistically signiﬁcant differences in age or
etween the groups. The Mini-Mental State Examination
(MMSE) scores in mild AD patients signiﬁcantly decreased in
comparison to control subjects. All the patients had MMSE values
of >17 (Table 1; available at www.aaojournal.org).
OCT. Compared with controls, in patients with mild AD:
(1) the thickness values for the central ring and the 4 inner quad-
rants were signiﬁcantly decreased (P< 0.05); (2) the RNFL
thickness of the outer macular quadrants were diminished; (3) only
the values of the outer temporal quadrant were signiﬁcantly lower
(P< 0.05); (4) the total macular volume was signiﬁcantly reduced
(P< 0.05); (5) peripapillary RNFL-thickness values and signal
strength did not differ between groups (P> 0.05; Fig 2A-D;
Table 2; available at www.aaojournal.org).
ROCs Curves. A signiﬁcant relationship was found between
the central and inner macular RNFL thickness in all areas. The
analysis of the ROCs curves showed that, for AD, the RNFL
thickness in the central and inner macular quadrants had the widest
areas under the ROCs curves for all the parameters analyzed
(0.743e0.771; P<0.05). The inner superior quadrant had the
strongest correlation (r ¼ 0.821; P< 0.01) followed by inner
temporal quadrant (r ¼ 0.806; P< 0.01). With respect to the total
macular area, the analysis revealed a strong correlation (r ¼ 0.742;
P< 0.01; Fig 2E-H; available at www.aaojournal.org).
Widespread axonal degeneration in the optic nerve had been
found both in postmortem and in vivo studies of AD patients.1-3 In
the present study, our mild AD patients, compared with a control
group, had a statistically signiﬁcant decrease in RNLF thickness, of
some macular regions and in the total macular volume. These data
are consistent with histopathologic studies1,3 demonstrating a
decrease of 25% of neurons in the ganglion-cell layer of the
macula; the greatest decrease being detected in the temporal region
of the fovea (52%).3
The ﬁrst reports on retinal involvement in AD stated that retinal
alterations occur as a consequence of a retrograde pathway.
However, it has recently been reported that neuroinﬂammation
induced by beta-amyloid-, APP- and tau deposits in the RGC- and
IPL layers could be causing direct retinal degeneration that may
account, at least in part, for the OCT alterations reported here. On
the other hand, the macular region contains the highest RGC
concentration of the retina, among which parvocellular RGC is the
predominant cell type. Notably, psychophysical exploration of the
parvocellular pathway are affected in AD.4,5
Our data showed values for the macular RNFL thickness and
total macular volume measured by OCT to have highly signiﬁcant
sensitivity and speciﬁcity for differentiating mild AD patients from
healthy subjects. The most sensitive area was the superior inner
macula, followed by the temporal inner macula, with ROCs values
of 85% and 80%, respectively. Thus, according to our data, the
superior inner macular RNFL thickness seems to have the highest
diagnostic value in AD neurodegeneration. To our knowledge, this
is the ﬁrst available report on the area of the central retina that has a
higher predictive ability in mild AD patients. Further studies to
conﬁrm this preliminary data are needed.
In comparison with other studies on histopathology and on
RNFL analysis by OCT in AD, our patients had: (1) similar mean1
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Figure 1. Retinal nerve ﬁber layer thickness analysis (RNFL). Optical coherence tomography (OCT) study. (A) Peripapillary OCT. Upper left: Peri-
papillary retinography with a green circle marking the retinal tissue considered for analysis. Upper right: diagram of the peripapillary quadrants analyzed:
temporal quadrant (316 to 45), superior quadrant (46 to 135), nasal quadrant (136 to 225), inferior quadrant (226 to 315). Bottom: retinal b-scan
and diagram of thickness normality. (B) Macular OCT. Upper left. Central retinography with a green square marking the retinal tissue considered for
analysis. Upper right: diagram showing the concentric rings and quadrants considered for analysis of the macular RNFL thickness and measurements
automatically provided by the analyser. Bottom: retinal b-scan of the macula. ETDRS ¼ Early Treatment Diabetic Retinopathy Study.
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Reportsage values, so differences in OCT ﬁndings seems not to be
attributable to aging and, (2) higher mean MMSE values seem to
indicate that they are taking place in early stages of AD.
Based on our data, we propose that the ﬁrst affected area of
the retina in mild AD may be the macular area. As the neuro-
degeneration progresses, a signiﬁcant decline in peripapillary
RNFL thickness becomes apparent. However, whether or not the
macula is really the ﬁrst area involved in early AD, or simply the
ﬁrst place with enough RGCs to discern an effect deserves further
investigation.
We suggest that with OCT we can detect consistent macular
changes that can be of signiﬁcant value for evaluating AD patients.
The retina, being part of the central nervous system and offering
easy accessibility, encourages its use as a potential biomarker for
AD diagnosis and progression.
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Table 1. Demographic and Clinical Data of the Study Groups
Variable AD (n [ 20) Control (n [ 28) P
Age (y), mean  SD 79.34.1 72.15.1 0.274
Gender 0.874
Male 8 9
Female 12 19
Race Caucasian Caucasian
MMSE (mean  SD) 23.73.3 28.12.1 0.009*
AD ¼ Alzheimer’s disease; MMSE ¼ Mini-Mental State Examination;
SD ¼ standard deviation.
*P< 0.01.
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Figure 2. Mean data of retinal nerve ﬁber layer (RNFL) thickness against eye quadrants assessed with optical coherence tomography and areas under the receiver
operating characteristics (ROCs) curve. (A-D) Central macular ring (1 mm from the fovea). Horizontal lines, bottom to top: 10th, 25th, 50th (median), 75th,
and 90th percentiles (A). Inner macular ring (3 mm from the fovea) (B). Outer macular ring (6 mm from the fovea) (C). Peripapillary retinal nerve-ﬁber layer
(D). (E-F) Areas under the ROCs curves in discriminating between mild Alzheimer disease patients and control subjects, from the central macular ring and total
macular volume (E), inner macular quadrants (F), outer macular quadrants (G) and peripapillary quadrants (H). *P < 0.01.
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Table 2. RNFL Thickness and Total Macular Volume
Retinal area of study AD group (mean ± SD) Control group (mean ± SD) % RNFL decrease P
Foveal thickness (mm) 221.221.6 243.724.8 9.24 0.015*
Inner macular quadrant (mm)
Superior area 283.411.1 294.918.1 3.91 0.002*
Inferior area 279.818.1 295.813.5 5.40 0.002*
Nasal area 285.617.2 300.115.1 4.83 0.007*
Temporal area 273.112.7 285.214.6 4.22 0.002*
Outer macular quadrant (mm)
Superior area 245.412.5 252.113.7 2.65 0.084
Inferior area 242.817.4 245.213.9 0.99 0.531
Nasal area 263.712.1 267.519.1 1.41 0.110
Temporal area 228.018.8 238.512.3 4.43 0.009*
Peripapillary thickness (mm)
Superior area 101.416.5 102.210.8 0.77 0.404
Inferior area 110.811.1 111.810.8 0.83 0.353
Nasal area 70.512.8 72.310.6 2.01 0.283
Temporal area 71.812.5 70.611.6 1.67 0.616
Total macular volume (cubic mm) 7.1 0.3 7.30.3 9.34 0.024*
Signal strength
Macula 70.8310.68 72.576.11 0.551
Peripapillar 74.858.61 73.137.07 0.503
AD ¼ Alzheimer’s disease; RNFL ¼ retinal nerve ﬁber layer; SD ¼ standard deviation.
*P< 0.05.
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